Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance
Polycystic Ovarian Syndrome (PCOS) is the main infertility cause due to metabolic and hormonal dysfunctions of the ovaries. This syndrome is comorbid with insulin resistance and substantially increases the risk of endometrial hyperplasia, obesity, breast cancer, myocardial infarction and stroke. Wom...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IP Berlin A.V.
2014-02-01
|
| Series: | Гинекология |
| Subjects: | |
| Online Access: | https://gynecology.orscience.ru/2079-5831/article/viewFile/28298/pdf |
| _version_ | 1818055434544611328 |
|---|---|
| author | O A Gromova E A Goncharova I Yu Torshin O A Limanova N V Kerimkulova |
| author_facet | O A Gromova E A Goncharova I Yu Torshin O A Limanova N V Kerimkulova |
| author_sort | O A Gromova |
| collection | DOAJ |
| description | Polycystic Ovarian Syndrome (PCOS) is the main infertility cause due to metabolic and hormonal dysfunctions of the ovaries. This syndrome is comorbid with insulin resistance and substantially increases the risk of endometrial hyperplasia, obesity, breast cancer, myocardial infarction and stroke. Women with PCOS have an increased risk of anovulatory cycles, infertility and miscarriage.One of the promising nutricial directions in the complex treatment of PCOS is the use of myo-inositol. A systematic analysis presented in this paper, showed that oral administration of myo-inositol at a dose of 2-4 g/day helps to reduce insulin resistance, excessive androgen secretion, the risk of hirsutism and acne, normalization of lipid profile and blood pressure. Its reception improves functioning of the reproductive axis in patients with PCOS, normalizes ovulation and formation of mature oocytes. Inclusion of myo-inositol in the process of preparing for the procedure of in vitro fertilization (IVF) can significantly improve the results in patients with PCOS and other disorders associated with infertility. |
| first_indexed | 2024-12-10T12:12:53Z |
| format | Article |
| id | doaj.art-89919ff2a02648ceb09049eb283245e9 |
| institution | Directory Open Access Journal |
| issn | 2079-5696 2079-5831 |
| language | Russian |
| last_indexed | 2024-12-10T12:12:53Z |
| publishDate | 2014-02-01 |
| publisher | IP Berlin A.V. |
| record_format | Article |
| series | Гинекология |
| spelling | doaj.art-89919ff2a02648ceb09049eb283245e92022-12-22T01:49:19ZrusIP Berlin A.V.Гинекология2079-56962079-58312014-02-01161586525428Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistanceO A GromovaE A GoncharovaI Yu TorshinO A LimanovaN V KerimkulovaPolycystic Ovarian Syndrome (PCOS) is the main infertility cause due to metabolic and hormonal dysfunctions of the ovaries. This syndrome is comorbid with insulin resistance and substantially increases the risk of endometrial hyperplasia, obesity, breast cancer, myocardial infarction and stroke. Women with PCOS have an increased risk of anovulatory cycles, infertility and miscarriage.One of the promising nutricial directions in the complex treatment of PCOS is the use of myo-inositol. A systematic analysis presented in this paper, showed that oral administration of myo-inositol at a dose of 2-4 g/day helps to reduce insulin resistance, excessive androgen secretion, the risk of hirsutism and acne, normalization of lipid profile and blood pressure. Its reception improves functioning of the reproductive axis in patients with PCOS, normalizes ovulation and formation of mature oocytes. Inclusion of myo-inositol in the process of preparing for the procedure of in vitro fertilization (IVF) can significantly improve the results in patients with PCOS and other disorders associated with infertility.https://gynecology.orscience.ru/2079-5831/article/viewFile/28298/pdfmyo-inositolpolycystic ovary syndromehyperinsulinemiapreparation for ivfinofert |
| spellingShingle | O A Gromova E A Goncharova I Yu Torshin O A Limanova N V Kerimkulova Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance Гинекология myo-inositol polycystic ovary syndrome hyperinsulinemia preparation for ivf inofert |
| title | Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance |
| title_full | Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance |
| title_fullStr | Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance |
| title_full_unstemmed | Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance |
| title_short | Myo-inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance |
| title_sort | myo inositol pregravidal training use prospects in women with polycystic ovary syndrome and insulin resistance |
| topic | myo-inositol polycystic ovary syndrome hyperinsulinemia preparation for ivf inofert |
| url | https://gynecology.orscience.ru/2079-5831/article/viewFile/28298/pdf |
| work_keys_str_mv | AT oagromova myoinositolpregravidaltraininguseprospectsinwomenwithpolycysticovarysyndromeandinsulinresistance AT eagoncharova myoinositolpregravidaltraininguseprospectsinwomenwithpolycysticovarysyndromeandinsulinresistance AT iyutorshin myoinositolpregravidaltraininguseprospectsinwomenwithpolycysticovarysyndromeandinsulinresistance AT oalimanova myoinositolpregravidaltraininguseprospectsinwomenwithpolycysticovarysyndromeandinsulinresistance AT nvkerimkulova myoinositolpregravidaltraininguseprospectsinwomenwithpolycysticovarysyndromeandinsulinresistance |